跳至主要内容
临床试验/NCT01917175
NCT01917175已完成不适用

Research Platform " Early Identification and Treatment of Early HIV Infection in Côte d'Ivoire "

ANRS, Emerging Infectious Diseases2 个研究点 分布在 1 个国家目标入组 511 人开始时间: 1997年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
511
试验地点
2
主要终点
Natural history of HIV infection in Sub-Saharan Africa

研究概览

简要总结

Set-up of a biobank for patients with an estimated date of infection seroconverters: store plasma and cells samples at initial contact and during follow-up for future analysis and analysis in international collaborative cohort seroconverters.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients included in the last Primo-CI ANRS 1220 protocol
  • All HIV infected individuals diagnosed during a blood donation with an estimated date of HIV seroconversion that will respect the following criteria: (i) age ≥18 (ii) HIV-1 or HIV-1+2 infected, (iii) HIV-seronegative at the preceding donation; (iv) who returned to the clinic to be informed of their HIV test result (v) with an HIV serology confirmed with two specific tests in two different laboratories (vi) who have never received ART for curative purpose
  • informed on study objectives and have a signed informed consent.

排除标准

  • Patient living outside of Abidjan

结局指标

主要结局

Natural history of HIV infection in Sub-Saharan Africa

时间窗: 12 months after ART initiation

Plasmatic HIV viral load and CD4 measured every six months and incidence of morbidity events associated with AIDS

次要结局

  • Evolution of markers of HIV infection and immunity(12 months after ART initiation)
  • Metabolic and lipodystrophic disorders(12 months after ART initiation)
  • Incidence of pregnancies(12 months after ART initiation)
  • Estimate the probability of disease progression after HIV seroconversion(12 months after ART initiation)
  • Viral genetic diversity description(Inclusion (J0))
  • Primary resistance to antiretroviral treatment(Inclusion (J0))
  • T lymphocytes activation and evolution in seroconverters(12 months after ART initiation)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验